Clinical Trials Logo

Clinical Trial Summary

Recent changes in medical training environments and restrictive work-hour regulations have greatly impacted trainees, limiting the number of opportunities to gain proficiency in procedural skills. Reports suggest that medical residents lack confidence in their ability to perform certain medical procedures, and program directors often do not believe their residents can operate independently in major procedures. Simulator based task training (SBTT) has provided a safe and ethically appropriate method of skill acquisition but training opportunities remain limited. Methods to enhance motor learning during these training opportunities have not been described. Transcranial direct-current stimulation (tDCS) is an emerging form of non-invasive brain stimulation that has been shown to improve motor learning. tDCS has been shown to enhance increasingly complex skill acquisition. The investigators propose to examine if tDCS can improve the acquisition and retention of neurosurgical skill. The investigators propose a double blind, sham-controlled randomized trial applying tDCS during evidence-based SBTT of medical students, to determine if brain stimulation can enhance training skill acquisition and retention. Even a modest enhancement carries the potential to transform medicosurgical skills training.


Clinical Trial Description

Rationale: Recent changes in medical training environments have resulted in many trainees lacking sufficient opportunity to acquire specific skills necessary for their specialty. New methods to enhance the acquisition and retention of medical and surgical skills are required to ensure the quality of the future physician workforce. Transcranial direct-current stimulation (tDCS) is an emerging method of non-invasive brain stimulation that has been show to safely enhance motor learning in adults and children. Even a modest enhancement of acquisition and retention of medical-surgical skill with tDCS carries the potential to accelerate skill training for health care providers, thereby contributing to greater training efficiency and improved patient outcomes.

Objectives: The objective of this study is to assess whether tDCS can enhance the acquisition and retention of neurosurgical ability.

Ethics:This study has been approval by the University of Calgary Research Ethics Board

Design: Randomized, double blind, sham-controlled trial to evaluate the ability of tDCS to enhance learning and retention of neurosurgical skills.

Transcranial Direct-Current Stimulation: The tDCS methods used are based on best-available evidence and practices, and will be applied in a standardized fashion by experienced investigators. Anodal tDCS will be delivered through saline-soaked sponge electrodes using a NeuroConn Direct-Current Stimulator (NeuroConn, Ilmenau, Germany). The anode will be centered over the left primary motor cortex (localized using the 10-20 EEG System), with the cathode over the contralateral supraorbital area. Both anodal and sham tDCS groups will have the current ramped-up to 1milliamp over 30 seconds. In the anodal tDCS group, the current will be held for 20 minutes. In the sham tDCS condition, the current will be held for only 60 seconds (no changes in cortical excitability) followed by a 30 second ramp-down.

Participants: Medical students (years 1-3) from the Cumming School of Medicine (University of Calgary) will be recruited. To ensure comparable baseline skills, trainees will be excluded if they have undergone formal neurosurgical training in the past 3 months.

Sample size calculations are based on the performance measures for the percentage of virtual tumor resected, determined through pilot studies. Based on 20% more tumor being resected at post-training, power of 90% and type-1 error of 0.05, the investigators estimate a sample size of a minimum of 24 participants (n=12 per stimulation condition).

Study Design: A short questionnaire will be completed to determine demographic characteristics, including: gender, age, level of training, how many times participants have performed on a virtual surgical simulator, how often participants play video games, and how often participants play a musical instrument.

Participants will be recruited at the Project NeuroArm Laboratory (University of Calgary) and be oriented to the workspace. Participants will complete virtual tumor resections on a NeuroTouch (National Research Council of Canada) surgical simulator. Participants will view a standardized training video, created by an expert in neurosurgery, demonstrating a virtual tumor resection using the simulator. Participant will have 3 minutes to resect a virtual tumor, avoiding resection of healthy tissue. Recorded outcome metrics will include: % tumor resected, volume of healthy tissue resected, time of excessive force on tumor and time of excessive force on healthy tissue.

Participants will perform one resection at baseline, establishing baseline skill. Participants will be randomized to receive sham or active tDCS by blinding selecting a code from the envelope, corresponding to a particular stimulation condition. Participants will perform eight training repetitions, taking approximately 30 minutes. Following approximately 30 minutes of training (eight training repetitions) the tDCS electrodes will be removed, and a final resection will be performed. Six weeks following the training the participants will return to assess retention of skill, performing a single resection. Emerging evidence suggests that a significant decay in surgical skill is present six weeks following training.

Data Analysis: Independent samples t-test will evaluate difference in outcome metrics at post-training between stimulation conditions. Two-way repeated-measures ANOVA for factors "stimulation type" and "training block" will explore the interaction between tDCS and training for each outcome metric. Retention of skill will be assessed using a paired t-test for each stimulation group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02987816
Study type Interventional
Source University of Calgary
Contact
Status Completed
Phase N/A
Start date November 2016
Completion date March 2017

See also
  Status Clinical Trial Phase
Completed NCT03682198 - Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions N/A
Withdrawn NCT00925093 - Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection Phase 1
Recruiting NCT05264012 - Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery
Recruiting NCT05397574 - Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
Completed NCT04153396 - Preemptive Infiltration With Betamethasone and Ropivacaine for Postoperative Pain in Laminoplasty or Laminectomy Phase 4
Recruiting NCT03087981 - Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition N/A
Completed NCT01513213 - Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient N/A
Recruiting NCT04034836 - Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain Phase 4
Completed NCT03532256 - Post-op Crowd Sourcing Health Data Via Text-messaging
Completed NCT05108337 - Superficial Cervical Plexus Block for Postoperative Chronic Pain N/A
Completed NCT03193905 - Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery N/A
Completed NCT00122096 - Perioperative Inflammation and Cyclooxygenase 2 (COX-2) Phase 4
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Completed NCT01122537 - Characterization and Differential Diagnosis of Postneurosurgical Meningitis N/A
Recruiting NCT05294185 - Intra-operative Hyperspectral Imaging in Neurosurgery
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Completed NCT05169281 - Distribution of Medication Disposal Packets - Acute Opioid Prescribing N/A
Recruiting NCT06264037 - The Experience in Neurorehabilitation Setting: a Qualitative Study
Recruiting NCT05860790 - Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
Completed NCT06068673 - The Potential Impact of Clindamycin on Neurosurgery Patients. N/A